Uridine-13C9,15N2

• UNSPSC Description:

  Uridine-13C9,15N2 (β-Uridine-13C9,15N2) is 13C and 15N labeled Uridine (HY-B1449). Uridine is a glycosylated pyrimidine-analog containing uracil attached to a ribose ring (or more specifically, aribofuranose) via a β-N1-glycosidic bond[1].

• Target Antigen:

  Endogenous Metabolite; Isotope-Labeled Compounds; Nucleoside Antimetabolite/Analog

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Cell Cycle/DNA Damage;Metabolic Enzyme/Protease;Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/uridine-13c9-15n2.html

• Purity:

  99.0

• Solubility:

  10 mM in DMSO

• Smiles:

  O[13C@H]1[13C@@H](O[13C@H]([13CH2]O)[13C@H]1O)[15N]2[13C](=O)[15NH][13C](=O)[13CH]=[13CH]2

• Molecular Weight:

  255.12

• References & Citations:

  [1]G P Connolly, et al. Uridine and its nucleotides: biological actions, therapeutic potentials. Trends Pharmacol Sci. 1999 May;20(5):218-25.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Solution, -20°C, 2 years

• Clinical Information:

  No Development Reported

• CAS Number:

  202406-84-6